Pacific Shuanglin Bio-pharmacy Co., LTD announced that at its Extraordinary General Meeting of 2023 held on 25 October 2023, approved: Election and nomination of Li Hao, Huang Xiaoying, Si Wenbin, Liu Zhiqiang, Ye Lan, Nie Qun, Zhou Qiao, Feng Hao as non-independent directors. The company also approved the election of Dong Zuojun, Yin Jun, Wang Wenqi, Zhang Yutian, Ma Jun, as independent directors and also approved the Election and nomination of Guo Hui, Zuo Chao, Zhang Suping as non-employee supervisor.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
27.31 CNY | -0.36% | -5.34% | +0.26% |
May. 09 | Pacific Shuanglin Bio-pharmacy Subsidiary Gets Plasmapheresis License | MT |
Apr. 26 | Pacific Shuanglin Bio-pharmacy Co., LTD Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+0.26% | 2.76B | |
-2.32% | 90.45B | |
+3.68% | 41.45B | |
-10.90% | 33.57B | |
+58.05% | 25.73B | |
-19.56% | 14.73B | |
-9.06% | 12.82B | |
-11.34% | 11.7B | |
-43.53% | 11.44B | |
+3.75% | 8.79B |
- Stock Market
- Equities
- 000403 Stock
- News Pacific Shuanglin Bio-pharmacy Co., LTD
- Pacific Shuanglin Bio-pharmacy Co., LTD Approves Board Appointments